Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer

Induction chemoradiation is used in the majority of patients with non-small cell lung cancer with N2 disease who undergo induction therapy before surgical resection, but it is not associated with improved survival compared with induction chemotherapy.